| Guideline | Drug Name |
|---|---|
| Rinvoq (upadacitinib) | Rinvoq (upadacitinib) ER tablets, Rinvoq LQ (upadacitinib) oral solution, Rinvoq (upadacitinib) extended-release (ER) tablets |
| Rituxan Hycela (rituximab and hyaluronidase human) | Rituxan Hycela (rituximab and hyaluronidase human) |
| Rituximab - PA, NF | Riabni (rituximab-arrx), Rituxan (rituximab), Ruxience (rituximab-pvvr), Truxima (rituximab-abbs) |
| Rivfloza (nedosiran) | Rivfloza (nedosiran) |
| Roctavian (valoctocogene roxaparvovec-rvox) | Roctavian (valoctocogene roxaparvovec-rvox) |
| Romvimza (vimseltinib) | Romvimza (vimseltinib) |
| Roszet (rosuvastatin/ezetimibe) - NF | Roszet (rosuvastatin/ezetimibe) |
| Rozlytrek (entrectinib) | Rozlytrek (entrectinib) |
| Rubraca (rucaparib) - PA, NF | Rubraca (rucaparib) |
| Rydapt (midostaurin) | Rydapt (midostaurin) capsules |
| Ryplazim (plasminogen, human-tvmh) | Ryplazim (plasminogen, human-tvmh) |
| Rystiggo (rozanolixizumab) | Rystiggo (rozanolixizumab) |
| Rytelo (imetelstat) | Rytelo (imetelstat) |
| Sabril, Vigadrone, Vigafyde, Vigpoder (vigabatrin) | Sabril (vigabatrin), Vigadrone (vigabatrin), Vigpoder (vigabatrin), Vigafyde (vigabatrin) |
| Saphnelo (anifrolumab-fnia) | Saphnelo (anifrolumab-fnia) |
| Sapropterin Products | Javygtor (sapropterin dihydrochloride), Kuvan (sapropterin dihydrochloride) |
| Scemblix (asciminib) | Scemblix |
| Scenesse (afamelanotide) | Scenesse (afamelanotide) |
| Selzentry (maraviroc) | Selzentry (maraviroc) |
| Sensipar (cinacalcet) | Sensipar (cinacalcet) |
HEALTHY LIVING